2-Methoxyaniline (o-anisidine) is an industrial and environmental pollutant causing tumors of urinary bladder in rodents. Here, we investigated the formation and persistence of DNA adducts in the Wistar rat. Using the 32 P-postlabeling method, three o-anisidine-derived DNA adducts were found in several organs of rats treated with a total dose of 0.53 mg o-anisidine/kg body wt (0.15, 0.18, and 0.2 mg/kg body wt ip in the first, second, and third day, respectively), of which the urinary bladder had the highest levels. At four posttreatment times (1 day, 13 days, 10 weeks, and 36 weeks), DNA adducts in bladder, liver, kidney, and spleen of rats were analyzed to study their persistence. In all time points, the highest total adduct levels were found in urinary bladder (39 adducts per 10 7 nucleotides after 1 day and 15 adducts per 10 7 nucleotides after 36 weeks) where 39% adducts remained. In contrast to the urinary bladder, no persistence was detected in other organs. All three DNA adducts were identified as deoxyguanosine adducts. When deoxyguanosine was reacted with the oxidative metabolite of o-anisidine, N-(2-methoxyphenyl)hydroxylamine, three adducts could be separated by highperformance liquid chromatography (HPLC) and were identified by mass spectroscopy and/or nuclear magnetic resonance spectrometry. All adducts are products of the nitrenium/carbenium ions, the reactive species generated from N-(2-methoxyphenyl)hydroxylamine. The major adduct was identified to be N-(deoxyguanosin-8-yl)-2-methoxyaniline. Using cochromatography on HPLC, this adduct was found to be identical to the major adduct generated by activation of o-anisidine in vitro and in vivo.
2-Methoxyaniline (o-anisidine) is an industrial and environmental pollutant causing tumors of urinary bladder in rodents. Here, we investigated the formation and persistence of DNA adducts in the Wistar rat. Using the 32 P-postlabeling method, three o-anisidine-derived DNA adducts were found in several organs of rats treated with a total dose of 0.53 mg o-anisidine/kg body wt (0.15, 0.18, and 0.2 mg/kg body wt ip in the first, second, and third day, respectively), of which the urinary bladder had the highest levels. At four posttreatment times (1 day, 13 days, 10 weeks, and 36 weeks), DNA adducts in bladder, liver, kidney, and spleen of rats were analyzed to study their persistence. In all time points, the highest total adduct levels were found in urinary bladder (39 adducts per 10 7 nucleotides after 1 day and 15 adducts per 10 7 nucleotides after 36 weeks) where 39% adducts remained. In contrast to the urinary bladder, no persistence was detected in other organs. All three DNA adducts were identified as deoxyguanosine adducts. When deoxyguanosine was reacted with the oxidative metabolite of o-anisidine, N-(2-methoxyphenyl)hydroxylamine, three adducts could be separated by highperformance liquid chromatography (HPLC) and were identified by mass spectroscopy and/or nuclear magnetic resonance spectrometry. All adducts are products of the nitrenium/carbenium ions, the reactive species generated from N-(2-methoxyphenyl)hydroxylamine. The major adduct was identified to be N-(deoxyguanosin-8-yl)-2-methoxyaniline. Using cochromatography on HPLC, this adduct was found to be identical to the major adduct generated by activation of o-anisidine in vitro and in vivo.
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2-Methoxyaniline (o-anisidine) is a potent carcinogen, causing tumors of urinary bladder in both genders of F344 rats and B6C3F1 mice (International Agency for Research on Cancer (IARC), 1982 (IARC), , 1999 NTP, 1979) . The IARC has classified o-anisidine as a group 2B carcinogen (IARC, 1982) , which is possibly carcinogenic to humans. o-Anisidine is used as an intermediate in the manufacturing of a number of pigments and dyes (Garner et al., 1984; NTP, 1979) . Such a wide use of this aromatic amine could result in occupational exposure. Furthermore, it may be released from textiles and leather goods colored with these azo dyes, and a large part of the population may be exposed. This carcinogen is also a constituent of cigarette smoke (IARC, 1982 (IARC, , 1999 Stabbert et al., 2003) . This strongly suggests that o-anisidine ranks not only among environmental pollutants; it can be assumed that human exposure is widespread. Indeed, o-anisidine was found in human urine sample in the general population, in concentrations of 0.22 lg/l (median) (Weiss and Angerer, 2003) . In addition, hemoglobin adducts of o-anisidine were detected in blood samples of persons living in urban or rural areas of Germany (Branner et al., 1998; Falter et al., 1994; Richter et al., 2001) .
In spite of potent rodent carcinogenicity, o-anisidine is weakly mutagenic (Ashby, 1995; Dunkel and Simmon, 1980; Dunkel et al., 1985) . A statistically significant DNA damage in urinary bladder of CD-1 mice exposed to o-anisidine determined by the single-cell gel electrophoresis (Comet) assay was detected (Glickman et al., 1993; Sasaki et al., 1998) . Moreover, Ashby and coworkers (Ashby et al., 1994; Glickman et al., 1993) demonstrated that a weak, but significant, increase in the frequency of mutations was induced in urinary bladder in transgenic lacI (Big Blue) mice treated with this carcinogen. However, the chemical is negative in other in vivo genotoxicity assays, including the mouse micronucleus test and the DNA single-strand break assay in rat liver, spleen, kidney, and bladder (Ashby et al., 1991; Morita et al., 1997) .
Recently, we have found that o-anisidine is oxidatively activated by peroxidase and cytochrome P450 (P450) to species binding to DNA in vitro (Naiman et al., 2010a (Naiman et al., ,b, 2011 Stiborová et al., 2002 Stiborová et al., , 2005 . We also demonstrated that o-anisidine forms DNA adducts in vivo. The same adducts as found in DNA incubated with o-anisidine and human microsomes in vitro were detected in urinary bladder, the target organ, and to a lesser extent, in liver, kidney, and spleen of rats treated with o-anisidine (Stiborová et al., 2005) . The o-anisidine-derived DNA adducts were identified as deoxyguanosine adducts formed from a P450-mediated metabolite of o-anisidine, N-(2-methoxyphenyl)hydroxylamine (Naiman et al., 2008 (Naiman et al., , 2010b Stiborová et al., 2005) . Besides N-hydroxylation of o-anisidine, O-sulfation of N-(2-methoxyphenyl)hydroxylamine was also found to be involved in activation reactions of this carcinogen (Stiborová et al., 2005) . However, the structures of the adducts formed during these reactions have not been identified as yet (Stiborová et al., 2005) . Therefore, the aim of the present work was to characterize the structure of these adducts.
The persistence of DNA adducts in different organs can vary as a result of their chemical stability or the DNA repair capacity of the organ. It was postulated that persistent DNA adducts represent dormant lesions that may become fixed as mutations long after exposure to the compounds and contribute to the malignant transformation as a results of cell division (Cui et al., 1999; Fernando et al., 1993; Randerath et al., 1985) . Therefore, to better evaluate a genotoxic effect of o-anisidine, the persistence of o-anisidine-derived DNA adducts generated in urinary bladder, liver, kidney, and spleen of rats treated with o-anisidine was investigated as another target of our present study.
MATERIALS AND METHODS
Chemicals. Chemicals were obtained from the following sources: o-anisidine (> 99% based on high-performance liquid chromatography, HPLC) and deoxyguanosine from Fluka Chemie AG (Buchs, Switzerland). All chemicals were of analytical purity or better. N-(2-methoxyphenyl)hydroxylamine was synthesized by a procedure similar to that described earlier (Balaban et al., 1998) . Briefly, to a solution of 2 g ammonium chloride and 90 mmol o-nitroanisole in 60% ethanol/water, 180 mmol zinc powder was added in small portions. After addition of the first portion at room temperature, the reaction starts; this can be monitored by the rising temperature in the flask. The reaction mixture was kept at 10-15°C using a cooling bath (ice/sodium chloride mixture) and slowly adding additional doses of zinc powder. After 1 h, excess zinc was removed by filtration and ethanol was removed under reduced pressure. The product was extracted into 100 ml ethyl acetate and crystallized by adding hexane. The yield was 60%. N-(2-methoxyphenyl)hydroxylamine authenticity was confirmed by electrospray mass and collision-induced dissociation (CID) spectra and high field proton NMR spectroscopy. The positive-ion electrospray mass spectrum exhibited the protonated molecule at m/z 140.1, whereas the CID exhibited its ion fragment at m/z 125.2, 108.1, and 109. Enzymes and chemicals for the 32 P-postlabeling assay were obtained commercially from sources described previously (Stiborová et al., 2004 (Stiborová et al., , 2005 .
Animal experiments. The study was conducted in accordance with the Regulation for the Care and Use of Laboratory Animals (311/1997, Ministry of Agriculture, Czech Republic), which complies with the Declaration of Helsinki. Eighteen male Wistar rats (125-150 g) were treated once a day for 3 consecutive days with o-anisidine dissolved in sunflower oil with a total dose of 0.53 mg o-anisidine/kg body wt (0.15 mg/kg body wt ip in the first day, 0.18 mg/kg body wt ip in the second day, and 0.2 mg/kg body wt ip in the third day). Two control animals received an equal volume of oil only. Rats were placed in cages in temperature and humidity controlled rooms. Standardized diet and water were provided ad libitum. Animals were sacrificed by cervical dislocation at the following time points: 1 day (three animals), 13 days (three animals), 10 weeks (six animals), and 36 weeks (six animals) after treatment. Two control animals were sacrificed after 36 weeks. The four organs where we found previously o-anisidine-derived DNA adducts (urinary bladder, liver, kidney, and spleen) (Stiborová et al., 2005) were removed immediately after death, quickly frozen in liquid nitrogen and stored at À80°C until DNA isolation.
Chemical synthesis of N-(2-methoxyphenyl)hydroxylamine-deoxyguanosine adducts. N-(2-methoxyphenyl)hydroxylamine is the reactive proximate carcinogen of o-anisidine and reacts with deoxyguanosine under acidic conditions. This reaction was utilized to prepare the N-(2-methoxyphenyl)hydroxylamine-mediated deoxyguanosine adducts. The reaction was carried out in a final volume of 1.0 ml as follows: 100mM sodium acetate buffer (pH 5), 1mM deoxyguanosine, and 3mM N-(2-methoxyphenyl)hydroxylamine dissolved in distilled water were reacted overnight at 23°C and the next day centrifuged at 5000 3 g for 5 min. Supernatants were collected, and 20-200 ll aliquots were applied onto an HPLC column, where the adducts formed from deoxyguanosine and N-(2-methoxyphenyl)hydroxylamine were separated, isolated from multiple HPLC runs, concentrated on a Speed-Vac evaporator, and analyzed by mass spectroscopy and/or NMR.
HPLC conditions. HPLC was performed on a C-18 reversed-phase column (250 3 4.6 mm, 5 lm, Nucleosil 100-5, Macherey-Nagel, Duren, Germany). To isolate N-(2-methoxyphenyl)hydroxylamine-mediated deoxyguanosine adducts, three different methanol gradients in 10lM formic acid were used (flow rate of 0.6 ml/min, detection at 234 and 254 nm).
Method 1: 0 % methanol up to 5 min, to 100% methanol up to 60 min, 100% methanol up to 65 min ( Fig. 2A, Fig. 6 ).
Method 2: 0-28 % methanol up to 15 min, to 32% methanol up to 50 min, to 100% methanol up to 55 min, 100% methanol up to 62 min (Fig. 2B ).
Method 3: 0-22 % methanol up to 10 min, to 23% methanol up to 50 min, to 100% methanol up to 55 min, 100% methanol to 60 min (Fig. 2C ).
Mass spectrometry. Positive-and negative-ion electrospray ionization mass spectra were recorded on a Finnigan LCO-DECA quadrupole ion trap mass spectrometer (ThermoFinnigan, San Jose, CA). Metabolites (final concentration 1 pmol/ll) dissolved in methanol/water (1:1 vol/vol) were continuously infused through a capillary held at 1.8 kV into the dynamic Finnigan nano-electrospray ion source with a linear syringe pump (Harvard Apparatus Model 22) at a rate of 1 ll/min. The ionizer and ion transfer optics parameters of the ion trap were as follows: spray voltage 1800 V, capillary temperature 150°C, capillary voltage 14 V, tube lens offset À22 V, octapole 1 offset À7.4 V, lens voltage À16 V, octapole 2 offset À11.3 V, octapole radio frequency amplitude 450 V peak-to-peak (pp), and entrance lens voltage À66.9 V. Helium was introduced at a presence of 0.1 Pa to improve the trapping efficiency of the sample ions. The spectra were scanned in the range m/z 50-800, and the gating time was set to accumulate and trap 1 3 10 7 ion. The mass isolation window for precursor ion selection was set to 2 amu and centered on the 12 C isotope of the pertinent ion. The background helium gas served as the collision gas for CID experiment. The relative activation amplitude was 35%, and the activation time was 30 ms. No broadband excitations were applied. NMR spectrometry. NMR spectra (d, ppm: J, Hz) were measured on a Bruker Avance II-600 instrument (600. 32 P-Postlabeling analysis and HPLC analysis of 32 P-labeled 3#,5# deoxyribonucleoside bisphosphate adducts. The standard procedure (Gupta et al., 1982) , this procedure under ATP-deficient conditions (Randerath et al., 1985) , and the nuclease P1 enrichment versions (Reddy and Randerath, 1986) of the 32 P-postlabeling assay were performed as described earlier (Randerath et al., 1985; Stiborová et al., 2004 Stiborová et al., , 2005 . One microgram of DNA was used for enzymatic digestion in the standard procedure and this procedure under ATP-deficient conditions, whereas 10 lg of DNA were used in the nuclease P1 enrichment version of the 32 P-postlabeling assay. 32 P-labeled DNA digests were separated by chromatography on polyethyleneimine (PEI)-cellulose plates, by the modification described to be suitable for resolution of DNA adducts formed by N-(2-methoxyphenyl)hydroxylamine or by o-anisidine, oxidatively activated in vitro and in vivo (Stiborová et al., 2005) . The solvents used were: D1, 2.3M sodium phosphate (pH 5.77); D2 was omitted; D3, 2.7M lithium formate, 5.1M urea (pH 3.5); D4, 0.36M sodium phosphate, 0.23M Tris-HCl, 3.8M urea (pH 8.0). After D4 development and brief water wash, the sheets were developed (along D4) in 1.7M sodium phosphate (pH 6.0) (D5), to the top of the plate, followed by an additional 30-40 min development with the thin layer chromatography (TLC) tank partially opened, to allow the radioactive impurities to concentrate in a band close to the top edge (Stiborová et al., 2004 (Stiborová et al., , 2005 . Adduct levels were calculated in units of relative adduct labeling (RAL), which is the ratio of cpm of adducted nucleotides to cpm of total nucleotides in the assay.
The TLC and HPLC procedures used for cochromatographic analyses were done as reported previously (Stiborová et al., 2004 (Stiborová et al., , 2005 .
32
P-Postlabeling of adducts in DNA of organs of rats treated with o-anisidine. Whole rat organs were homogenized and DNA was isolated by the phenol/chloroform extraction method.
P-Postlabeling analysis was performed as described above.
Preparation of reference compounds and 32 P-postlabeling analysis of adduct. To prepare the reference standard 0.5 lmol dGp was incubated in 50mM Tris-HCl buffer, pH 5.0, 7.0, or 7.4 with 20 lmol N-(2-methoxyphenyl)hydroxylamine without further activation at 37°C overnight in a total volume of 0.5 ml (Stiborová et al., 2005) . After incubation and extraction with ethyl acetate, 20 ll aliquots were removed from the aqueous phase and directly used for 32 Ppostlabeling analysis; the standard procedure and the nuclease P1 version of the assay were utilized (Stiborová et al., 2005) . Control incubations were carried out either without N-(2-methoxyphenyl)hydroxylamine or without dGp. Resolution of the adducts on a PEI-cellulose TLC plate was carried out as described above.
The spot of the major adduct formed from N-(2-methoxyphenyl)hydroxylamine and dGp was excited from multiple thin-layer plates and extracted with two 800 ll portions of 6M ammonium hydroxide/isopropanol (1:1) for a total 40 min (Stiborová et al., 2004 (Stiborová et al., , 2005 . The eluent was evaporated in a Speed-Vac centrifuge. The extracts collected from multiple runs were dissolved in distilled water and treated with micrococcal nuclease/spleen phosphodiesterase followed by nuclease P1 in suitable digestion buffers to dephosphorylate 3# and 5# phosphate residues from the adduct. After enzymatic treatment, the extract was heated (90°C for 20 min) and centrifuged at 15,000 3 g for 10 min to remove the enzyme proteins. Chromatography on HPLC with method 1 (see above) was performed to check if the synthetic deoxyguanosine N-(2-methoxyphenyl)hydroxylamine adduct and the dephosphorylated 32 P-labeled dGp adduct, which is identical to the DNA adduct of o-anisidine in bladder, were indeed identical.
RESULTS

DNA Adduct Formation by o-Anisidine in Rats Detected by
32 P-Postlabeling DNA was isolated from four organs of Wistar rats treated ip once a day for 3 consecutive days with o-anisidine at a total dose of 0.53 mg/kg body wt and analyzed by the 32 P-postlabeling assay. Urinary bladder, liver, kidney, and spleen were chosen because we previously found o-anisidine-DNA adducts in these organs (Stiborová et al., 2005) . The standard procedure (Gupta et al., 1982) , this procedure under the ATP-deficient conditions (Randerath et al., 1985) , and the nuclease P1 version (Reddy and Randerath, 1986 ) of the 32 P-postlabeling assay were used to analyze o-anisidine-DNA adducts. Using the nuclease P1 version of the 32 P-postlabeling assay, up to three DNA adducts (see adduct spots 1-3 in Fig. 1 ) were detected in four organs of rats treated with o-anisidine ( Table 1 ). The highest levels were found in the target organ for the o-anisidine carcinogenicity, the urinary bladder, followed by liver, kidney, and spleen (Table 1) . Using TLC and HPLC cochromatography (Stiborová et al., 2005) , these DNA adducts were found to be chromatographically indistinguishable from those formed in dGp reacted with N-(2-methoxyphenyl)-hydroxylamine (data not shown). DNA samples of the urinary bladder of control (solvent treated) rats were free of these adduct spots even after prolonged exposure times (Fig. 1F) .
The major adducts resulting from N-hydroxylamines, including those from N-hydroxylanilines (Marques et al., 1997) are the C8 adducts of dGp. These adducts are frequently dephosphorylated by nuclease P1 and therefore will not be detected by the nuclease P1 version of the 32 P-postlabeling assay. The o-anisidine-DNA adduct 3 (see spot 3 in Fig. 1 ) is sensitive to dephosphorylation by nuclease P1 (Fig. 1 and Table 1 ) because with the standard procedure of the 32 P-postlabeling assay, almost 30-fold higher RAL was found for the adduct 3 than if DNA was analyzed with the nuclease P1 version of the assay (Table 1 ). In liver, kidney, and spleen, no o-anisidine- 
derived DNA adducts were detectable with the standard 32 Ppostlabeling method, which is less sensitive than the nuclease P1 version (Table 1 ). The standard procedure under ATP-deficient conditions (Randerath et al., 1985) renders the assay more sensitive and indeed with the procedure, all three o-anisidine-derived DNA adducts were detectable also in liver, kidney, and spleen (Table 1) .
Persistence of o-Anisidine-DNA Adducts in Rats
Levels of o-anisidine-derived DNA adducts were analyzed in urinary bladder, liver, kidney, and spleen of rats not only 1 day, but also 13 days, and 10 and 36 weeks after the last administration of a total dose of 0.53 mg o-anisidine/kg body wt. For analyses of persistence of DNA adducts in the urinary bladder, the standard procedure and the nuclease P1 version of the 32 P-postlabeling assay were again used. For DNA from liver, kidney, and spleen, these two methods and the standard procedure under ATPdeficient conditions were employed for analyses (Table 1B-D) .
Maximum adduct levels in tissues were always found 1 day posttreatment (Table 1) , the earliest time point at which DNA samples were collected. As shown in Table 1 , persistence of o-anisidine-derived DNA adducts differed in the four rat tissues. The highest total DNA binding was found in the urinary bladder at all time points and showed the longest persistence. Thirteen days after administration of o-anisidine more than 50% of the adducts persisted in bladder, whereas in the other organs > 90% of adducts were either repaired or lost (Table 1) .
As shown in Table 1A , for urinary bladder, total adduct levels decreased over time to about 39% of the initial level after 36 weeks. DNA adduct elimination kinetics in the urinary bladder showed a biphasic profile with a steep decline during the first 13 days, followed by a very stable plateau up to 36 weeks (Table 1) .
In the DNA from liver, kidney, and spleen, the o-anisidinederived adducts were detectable only up to 13 days after administration of o-anisidine at levels of approximately 10% of those on day 1 (Table 1B-D) .
Synthesis and Characterization of Adducts Formed From
Deoxyguanosine and N-(2-Methoxyphenyl)hydroxylamine
To characterize the o-anisidine-derived DNA adducts found in vivo, we reacted deoxyguanosine (the target base in DNA, Stiborová et al., 2005) with N-(2-methoxyphenyl)hydroxylamine, the proximate carcinogen formed after enzymatic activation of o-anisidine (Naiman et al., 2008 (Naiman et al., , 2011 Stiborová et al., 2005) as standard in sufficient quantity for structural characterization by mass spectroscopy (MS) and if possible by NMR.
The reaction of N-(2-methoxyphenyl)hydroxylamine with deoxyguanosine at pH 5.0 gave three adducts that were separated by HPLC (method 1, Fig. 2A ). The major adduct peak, eluting at 41.9 min was purified by additional chromatography (at least four times) under the same conditions to obtain this adduct at high purity for its further structural characterization by mass and NMR spectrometry. 
Note. Total RAL values are shown in bold.
a RAL values represent mean ± SD (n ¼ 3 and n ¼ 6). When using HPLC method 2 (see the Materials and Methods section), two minor deoxyguanosine adducts were clearly separated from deoxyguanosine and the major adduct (Fig. 2B) .
Both minor adducts, isolated by this HPLC procedure, were additionally rechromatographed and utilized for their further structural characterization by MS.
FIG. 2.
HPLC elution profile of the reaction mixture where N-(2-methoxyphenyl)hydroxylamine-mediated deoxyguanosine adducts were synthesized (pH 5.0) (A), those of the major and two minor adducts formed from deoxyguanosine and N-(2-methoxyphenyl)hydroxylamine (pH 5.0) (B), and of isolated minor adducts (C). HPLC method 1 was used in (A), method 2 in (B), and method 3 in (C). Methanol gradient used for separation of adducts is shown in the figure (the violet dashed line, color available online).
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On positive and negative ion MS, all adducts gave molecular ions at m/z 388.4 and 387.0 (Fig. 3) , corresponding to the adducts of deoxyguanosine with nitrenium/carbenium ion of o-anisidine.
The structure of the major deoxyguanosine adduct formed from deoxyguanosine and N-(2-methoxyphenyl)hydroxylamine was elucidated from 1 H (Fig. 4A) [H,C-HMBC] ). Four signals of aromatic hydrogens corresponding to one spin system (1,2-disubstituted benzene) were present in the 1 H spectrum at 7 ppm, but no signal corresponding to the hydrogen in position 8 of the guanine residue was found (see Fig. 4B for numbering) . Using COSY and heteronuclear correlation experiments, deoxyribose bound to the nitrogen in position 9 of guanine and N-substituted 2-methoxyaniline bound to position 8 of guanine were evident. The most important bond HMBC correlations were H1#-C4, H1#-C8, ArNH-Ar2, and ArNH-Ar6. The NH hydrogen of anisidine is in space vicinity (determined from ROESY) of hydrogens 1#, 2#, 3#, 5#, and 5#' of the deoxyribose residue, of the methoxy group and of the hydrogen Ar6. The ROESY contacts further confirmed the structure of the adduct to be N-(deoxyguanosin-8-yl)-2-methoxyaniline (Fig. 4B) .
N-(Deoxyguanosin-8-yl)-2-Methoxyaniline Adduct Is the
Major DNA Adduct Formed by o-Anisidine in DNA In Vitro and In Vivo Using HPLC method 1, we compared the chromatographic properties of the N-(deoxyguanosin-8-yl)-2-methoxyaniline adduct with those of the dephosphorylated adduct formed from dGp and N-(2-methoxyphenyl)hydroxylamine (see the adduct spot 3 in Fig. 1 detected as 3#,5#-bisphosphate by the 32 Ppostlabeling assay) (Fig. 5A ). This adduct is identical to that formed in DNA in vitro by o-anisidine activated with microsomes (Stiborová et al., 2005) and in vivo in rats treated with this carcinogen (Stiborová et al., 2005 and present study) . The dephosphorylated adduct 3 showed the same retention time as the synthetic N-(deoxyguanosin-8-yl)-2-methoxyaniline (Fig. 5) . Adduct 3 is sensitive to nuclease P1, which further characterize it as an adduct in position 8 in deoxyguanosine.
DISCUSSION
The results found in this and former (Stiborová et al., 2005) studies demonstrate that o-anisidine form multiple covalent DNA adducts in four organs in rats treated with this carcinogen. The adduct pattern consisted of three DNA adducts formed from activated o-anisidine, which we shown previously to be formed from the nitrenium/carbenium ions generated from N-(2-methoxyphenyl)hydroxylamine (Fig. 6) . We found that nuclease P1 digestion led to pronounced dephosphorylation of one adduct (spot 3 in Fig. 1 ), the major adduct formed from dGp and N-(2-methoxyphenyl)hydroxylamine detectable by the 32 P-postlabeling assay without the nuclease P1 enrichment. Because of its sensitivity to nuclease P1, which is a general feature on N-(deoxyguanosin-8-yl) arylamine 3# phosphates, this adduct was suggested previously (Stiborová et al., 2005) to be N-(deoxyguanosin-8-yl)-2-methoxyaniline. In the present study, using mass spectroscopy and NMR spectrometry, the proposed structure of the DNA adduct was confirmed. Deoxyguanosine reacted with N-(2-methoxyphenyl)hydroxylamine under acidic conditions (pH 5.0) resulted in the same adduct as the major adduct formed from o-anisidine in rats in vivo, and it is N-(deoxyguanosin-8-yl)-2-methoxyaniline. The other two adducts formed by the reaction of deoxyguanosine with N-(2-methoxyphenyl)hydroxylamine have the same molecular mass as the major adduct. These two adducts are probably products of reactions of the nitrenium or carbenium ion with nucleophilic centers N 2 -and O 6 -in deoxyguanosine, where N 2 -adduct may be the most prominent. The results found in this and previous (Stiborová et al., 2005) studies, showing formation of covalent DNA adducts by o-anisidine, demonstrate a genotoxic mechanism of o-anisidine carcinogenicity. The highest levels of DNA adducts were always found in the urinary bladder; however, DNA adduct formation was seen also in liver, kidney, and spleen, but at levels more than one, order of magnitude lower than in the urinary bladder. The levels of DNA adducts expressed as RAL indicate that the binding was in the order of four adducts per 10 6 nucleotides in DNA of the urinary bladder. This is similar to what has been observed for the levels of adducts in the urinary bladder of mice fed other carcinogenic amines (Poirier et al., 1991 (Poirier et al., , 1995 .
Several studies have found a positive correlation between DNA adduct levels of carcinogens or genotoxic agents, their persistence and their mutagenicity in the target organ and/or tumor formation (Godschalk et al., 2000; Poirier, 2004; Randerath et al., 1984; Ross et al., 1995; Smith et al., 1995) . To better understand the role of o-anisidine-DNA adducts for potential genotoxic effects of this carcinogen, we analyzed the FIG. 5 . HPLC elution profiles of the purified major deoxyguanosine adduct formed by N-(2-methoxyphenyl)hydroxylamine reacted with deoxyguanosine (A) and of the major adduct formed from dGp and N-(2-methoxyphenyl)hydroxylamine isolated from TLC plates after 32 P-postlabeling and after its dephosphorylation to the dG adduct (B). HPLC method 1 was used. Gradient used for separation of adducts is shown in the figure (the violet dashed line, color available online).
356 NAIMAN ET AL. persistence of the DNA adducts in the urinary bladder, liver, kidney, and spleen of rats treated with o-anisidine. The DNA adducts in liver, kidney, and spleen were not detectable 10 weeks after treatment probably because they decreased below the detection levels of the methods used. In the urinary bladder, however, levels of the o-anisidine-derived DNA adducts decreased to 46% initially up to 13 days, then remained at a very stable levels up to 36 weeks after treatment. Similar pharmacokinetics for DNA adduct persistence in target organs has been reported already for several other genotoxic agents (Bieler et al., 2007; Fernando et al., 1993; Godschalk et al., 2000; Poirier, 2004; Randerath et al., 1985 Randerath et al., , 1984 Ross et al., 1995; Smith et al., 1995; Stiborová et al., 2007) . Studies on DNA adduct persistence over periods longer than 20 weeks are rare. For example, Randerath et al. (1985) reported a rapid initial loss of 7,12-dimethylbenz[a]anthracene (DMBA) DNA adducts in mouse skin after topical application of DMBA followed by virtually constant levels up to 42 weeks even in this rapidly proliferating tissue. It is not clear why a fraction of the damage persists, even in a proliferating tissue such as skin or, as in our case, urinary bladder. Levels of DNA adducts of the plant carcinogen aristolochic acid I and the air pollutant 3-nitrobenzanthrone also showed similar persistence up to 36 weeks posttreatment (Bieler et al., 2007; Fernando et al., 1993) where 30% of the initial adduct levels remained in target organs. Also in the case of o-anisidine-derived DNA adducts, persistent levels of 39% of the initial adducts remained in the urinary bladder.
These findings are highly consistent with the carcinogenic activity of o-anisidine; it induces the highest levels of persistent adducts in DNA of the urinary bladder, which is also the target organ of neoplastic transformation (IARC, 1982 (IARC, , 1999 NTP, 1979) .
We have now identified the structure of the major DNA adduct formed by o-anisidine in vivo and have suggested the structures of the two minor deoxyguanosine adducts. This study can form the basis for the development of methods to monitor human exposure. To better understand the potential role of o-anisidine-DNA adducts in induction of cancer, our results require confirmation by additional animal studies, where the dose-dependent formation and persistence of o-anisidine-DNA adducts in target tissues after inhalation and oral exposure shall be monitored. These routes are more relevant for human exposure to this carcinogen.
